KLAC Form 4: Ahmad A. Khan Disposes 4,564 Shares; RSUs Make Up Majority of Holdings
Rhea-AI Filing Summary
Ahmad A. Khan, an officer of KLA Corporation (KLAC) and President, Semi. Prod. & Cust., reported an insider sale on 09/05/2025. The filing shows 4,564 shares of KLA common stock were sold at a reported price of $900 per share. Following the sale, the reporting person beneficially owned 22,808.252 shares, which includes 21,716.968 shares issuable upon vesting of restricted stock units (RSUs). The sale was made pursuant to a Rule 10b5-1 trading plan adopted May 30, 2025. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Positive
- Sale executed under a Rule 10b5-1 trading plan, indicating a prearranged, documented disposition
- Transparent reporting with Form 4 filed and attorney-in-fact signature
Negative
- Reduction in direct holdings by 4,564 shares following the sale
Insights
TL;DR: Officer sold 4,564 shares under a prearranged 10b5-1 plan; post-sale holdings include significant RSUs.
The sale appears to be a scheduled disposition under a Rule 10b5-1 plan adopted May 30, 2025, which generally reduces the likelihood the trade was based on material nonpublic information. The report shows a high proportion of reported beneficial ownership tied to unvested RSUs (21,716.968 of 22,808.252 shares), highlighting that most economic exposure is in restricted awards rather than freely tradable shares. For investors, this filing documents insider liquidity but does not by itself indicate a change in company fundamentals.
TL;DR: Transaction follows a documented 10b5-1 plan and was properly reported on Form 4.
The disclosure identifies the reporter's role and that the sale was effected pursuant to an established 10b5-1 trading plan, which is consistent with good governance practices for scheduled insider sales. The filing also notes an attorney-in-fact signature, indicating the report was filed by an authorized representative. The concentration of shares in unvested RSUs is relevant to governance discussions about executive compensation alignment but this Form 4 provides only transactional detail, not compensation terms or vesting schedules beyond the share count included.